Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Mabs|December 12, 2017
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodiesThomas Van Blarcom, Kevin Lindquist, Zea Melton, et al.Bioconjugate Chemistry|February 3, 2015
Effect of attachment site on stability of cleavable antibody drug conjugatesMagdalena Dorywalska, Pavel Strop, Jody A Melton-Witt, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 22, 2019
Preclinical Evaluation of Allogeneic CAR T Cells Targeting BCMA for the Treatment of Multiple MyelomaCesar Sommer, Bijan Boldajipour, Tracy C Kuo, et al.Journal of Molecular Biology|May 1, 2012
Generating bispecific human IgG1 and IgG2 antibodies from any antibody pairPavel Strop, Wei-Hsien Ho, Leila M Boustany, et al.Journal of Medicinal Chemistry|November 6, 2020
Design, Synthesis, and Structure-Activity Relationships of Novel Tetrahydroisoquinolino Benzodiazepine Dimer Antitumor Agents and Their Application in Antibody-Drug ConjugatesNaidu S Chowdari, Yong Zhang, Ivar McDonald, et al.Scientific Reports|March 4, 2022
Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo modelJulie A Zorn, Matthew L Wheeler, Ralston M Barnes, et al.Cell Host & Microbe|July 2, 2014
Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangementsKatherine J L Jackson, Yi Liu, Krishna M Roskin, et al.Chemistry & Biology|February 27, 2013
Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugatesPavel Strop, Shu-Hui Liu, Magdalena Dorywalska, et al.Molecular Cancer Therapeutics|August 23, 2019
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple MyelomaSiler H Panowski, Tracy C Kuo, Yi Zhang, et al.The Journal of Clinical Investigation|March 22, 2022
Tim-3 mediates T cell trogocytosis to limit antitumor immunityOrnella Pagliano, Robert M Morrison, Joe-Marc Chauvin, et al.Pageof 7